Literature DB >> 28522656

Comparison between Different Measures of Body Fat with Kidney Function Decline and Incident CKD.

Magdalena Madero1, Ronit Katz2, Rachel Murphy2, Anne Newman2, Kushang Patel2, Joachim Ix2, Carmen Peralta2, Suzanne Satterfield2, Linda Fried2, Michael Shlipak2, Mark Sarnak2.   

Abstract

BACKGROUND AND OBJECTIVES: Although anthropometric measures of body fat are associated with development of CKD, they may not be able to distinguish between various forms of fat and therefore may be less accurate than computed tomography (CT) measures. We compared the association of CT and anthropometric measures of obesity with kidney outcomes in the Health Aging and Body Composition Study. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Participants were recruited from March of 1997 through July of 1998. CT measures included visceral abdominal fat (VAT), subcutaneous adipose tissue (SAT), and intermuscular fat area (IMAT), whereas anthropometric measures included waist circumference (WC) and body mass index (BMI). Kidney outcomes included kidney function (KF) decline (30% decrease in eGFRcysC in follow-up at either year 3 or 10) or incident CKD (follow-up eGFRcysC≤60 ml/min per 1.73 m2 in individuals with baseline GFR>60 ml/min per 1.73 m2). Multivariable logistic regression models and Poisson regression models were used to evaluate the association with decline in KF and incident kidney disease, respectively. We also assessed for the independent associations among the exposure measures by including them in the same model.
RESULTS: Two-thousand four-hundred and eighty-nine individuals were included. Mean age was 74±3 years, 49% were men, 39% were black, 59% were hypertensive, and 15% were diabetic. KF decline occurred in 17% of the population, whereas incident CKD also occurred in 17% of those at risk. In continuous models, SAT, VAT, IMAT, BMI, and WC (per SD increase) were all significantly associated with KF decline. There was a significant interaction between VAT and CKD with regard to KF decline (P=0.01). Only VAT, BMI, and WC were associated with incident CKD. Only VAT remained a significant risk factor for incident CKD when other exposure variables were included in the same model. There was no association between any measure of obesity and kidney outcomes when creatinine values at years 3 and 10 were used to estimate changes in eGFR.
CONCLUSIONS: Anthropometric measures of body fat appear to provide as consistent estimates of KF decline risk as CT measures in elders.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  Aged; Body Composition; Body Mass Index; Follow-Up Studies; Humans; Intra-Abdominal Fat; Logistic Models; Male; Renal Insufficiency, Chronic; Subcutaneous Fat; Subcutaneous Fat, Abdominal; Tomography; Tomography, X-Ray Computed; Waist Circumference; chronic kidney disease; diabetes mellitus; obesity; renal function decline; risk factors

Mesh:

Substances:

Year:  2017        PMID: 28522656      PMCID: PMC5460706          DOI: 10.2215/CJN.07010716

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  34 in total

Review 1.  Obesity, metabolic syndrome, and cardiovascular disease.

Authors:  Scott M Grundy
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 2.  Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

Authors:  Susan P Bagby
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

3.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

4.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

5.  Combined renal effects of overweight and hypertension.

Authors:  J Ribstein; G du Cailar; A Mimran
Journal:  Hypertension       Date:  1995-10       Impact factor: 10.190

6.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

7.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Authors:  Asaf Vivante; Eliezer Golan; Dorit Tzur; Adi Leiba; Amir Tirosh; Karl Skorecki; Ronit Calderon-Margalit
Journal:  Arch Intern Med       Date:  2012-11-26

8.  Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

Authors:  J M Chan; E B Rimm; G A Colditz; M J Stampfer; W C Willett
Journal:  Diabetes Care       Date:  1994-09       Impact factor: 19.112

9.  Waist circumference, not body mass index, is associated with renal function decline in korean population: hallym aging study.

Authors:  Hyunju Oh; Shan Ai Quan; Jin-Young Jeong; Soong-Nang Jang; Jung Eun Lee; Dong-Hyun Kim
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

Review 10.  Intermuscular fat: a review of the consequences and causes.

Authors:  Odessa Addison; Robin L Marcus; Paul C Lastayo; Alice S Ryan
Journal:  Int J Endocrinol       Date:  2014-01-08       Impact factor: 3.257

View more
  25 in total

1.  Impact of visceral fat area in patients with chronic kidney disease.

Authors:  Shun Manabe; Hiroshi Kataoka; Toshio Mochizuki; Kazuhiro Iwadoh; Yusuke Ushio; Keiko Kawachi; Kentaro Watanabe; Saki Watanabe; Taro Akihisa; Shiho Makabe; Masayo Sato; Naomi Iwasa; Rie Yoshida; Yukako Sawara; Norio Hanafusa; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2021-02-17       Impact factor: 2.801

2.  The Association Between Hypertriglyceridemic-Waist Phenotype and Chronic Kidney Disease in Patients with Type 2 Diabetes: A Cross-Sectional METAL Study.

Authors:  Yan Xuan; Wen Zhang; Yuying Wang; Bin Wang; Yi Chen; Fangzhen Xia; Kun Zhang; Qing Li; Ningjian Wang; Yingli Lu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-20       Impact factor: 3.249

3.  Slope of Kidney Function and Its Association with Longitudinal Mortality and Cardiovascular Disease among Individuals with CKD.

Authors:  Paula F Orlandi; Dawei Xie; Wei Yang; Jordana B Cohen; Rajat Deo; Ana C Ricardo; Sarah Schrauben; Xue Wang; L Lee Hamm; Jiang He; James H Sondheimer; Krishna Kallem; Raymond Townsend; Dominic Raj; Afshin Parsa; Amanda H Anderson; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2020-10-06       Impact factor: 10.121

4.  Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients.

Authors:  Giulio Geraci; Marta Maria Zammuto; Alessandro Mattina; Luca Zanoli; Calogero Geraci; Antonio Granata; Emilio Nardi; Pasquale Mario Fatuzzo; Santina Cottone; Giuseppe Mulè
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-14       Impact factor: 3.738

5.  The Clinical Usefulness of Measurement of Visceral Fat Area Using Multi-Frequency Bioimpedance: The Association with Cardiac and Renal Function In General Population with Relatively Normal Renal Function.

Authors:  Hye Eun Yoon; Sang Su Choi; Yaeni Kim; Seok Joon Shin
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

6.  Visceral Adiposity Index and Chronic Kidney Disease in a Non-Diabetic Population: A Cross-Sectional Study.

Authors:  Hua Xiao; Chongxiang Xiong; Xiaofei Shao; Peichun Gao; Haishan Chen; Jing Ning; Yunying Chen; Ziliang Zou; Guobao Hong; Xiaolin Li; Xu You; Jieli Sheng; Fan Wu; Xin Wang; Hequn Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-04       Impact factor: 3.168

Review 7.  Strategies to Treat Obesity in Patients With CKD.

Authors:  Kiran Chintam; Alex R Chang
Journal:  Am J Kidney Dis       Date:  2020-10-16       Impact factor: 8.860

Review 8.  Organ crosstalk: the potent roles of inflammation and fibrotic changes in the course of organ interactions.

Authors:  Ferah Armutcu
Journal:  Inflamm Res       Date:  2019-07-20       Impact factor: 4.575

9.  Obesity-associated glomerular inflammation increases albuminuria without renal histological changes.

Authors:  Akira Mima; Toshinori Yasuzawa; George L King; Shigeru Ueshima
Journal:  FEBS Open Bio       Date:  2018-02-26       Impact factor: 2.693

10.  Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD.

Authors:  Sankar D Navaneethan; John P Kirwan; Erick M Remer; Erika Schneider; Bryan Addeman; Susana Arrigain; Ed Horwitz; Jeffrey C Fink; James P Lash; Charles A McKenzie; Mahboob Rahman; Panduranga S Rao; Jesse D Schold; Tariq Shafi; Jonathan J Taliercio; Raymond R Townsend; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2020-08-13       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.